EVOTEC AG
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About EVOTEC AG
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
/ 
Frequently asked questions
To buy EVOTEC AG stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for EVOTEC AG by name or ticker, choose the number of shares, and place your order.
The ticker symbol for EVOTEC AG is EVTG:xetr. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
EVOTEC AG has its primary listing on Deutsche Börse (XETRA). You can trade EVOTEC AG with a Saxo account, alongside thousands of other stocks worldwide.
Yes, EVOTEC AG is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include EVOTEC AG as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like EVOTEC AG.